Arteris CEO Janac sells $111,442 in stock

Published 05/04/2025, 01:40
Arteris CEO Janac sells $111,442 in stock

Arteris , Inc. (NASDAQ:AIP), whose stock has declined over 41% year-to-date and is currently trading near its 52-week low of $5.76, recently saw a series of stock sales by its President and CEO, Janac K. Charles. According to InvestingPro data, despite the recent price weakness, the company maintains impressive gross profit margins of nearly 90%. According to a recent SEC filing, Charles sold a total of 16,300 shares of the company’s common stock over two days. On April 2, he sold 7,150 shares at an average price of $7.1186, totaling approximately $50,897. The following day, April 3, he sold an additional 9,150 shares at a weighted average price of $6.617, amounting to about $60,545. These transactions were made under a 10b5-1 trading plan, which Charles had adopted on February 27, 2024. Following these sales, Charles continues to hold a significant number of shares in the company both directly and indirectly. Notably, while the stock appears oversold based on technical indicators, analysts maintain price targets ranging from $11 to $16, suggesting potential upside from current levels.

In other recent news, Arteris, Inc. has reported revenue that met expectations for the quarter, with guidance aligning with forecasts. Northland analysts have responded by raising their price target for Arteris shares from $14.00 to $16.00, maintaining an Outperform rating. This adjustment comes as Arteris announced its new product, FlexGen, which is expected to provide a 30% average selling price uplift, with 13 customers currently evaluating it. Meanwhile, Jefferies analyst Blayne Curtis also increased Arteris’ price target from $7.00 to $11.00, maintaining a Hold rating, citing recent progress in the microcontroller unit market and the potential of the FlexGen solution.

Despite these positive developments, Jefferies remains cautious due to lower-than-expected 2025 guidance. Additionally, Arteris has disclosed the resignation of board member Isabelle F. Geday for personal reasons, with no immediate plans for her replacement. Geday’s departure was announced in a recent SEC filing, and her contribution to the board since 2020 has been acknowledged as exemplary. Arteris continues to navigate the competitive semiconductor industry, with these recent developments reflecting strategic shifts that could influence its financial performance in the future.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.